Table 1.
Parameter | B | χ2 | SE | P | Hazard ratio |
Sex | 0.319 | 1.652 | 0.248 | 0.199 | 1.375 |
Age | -0.006 | 0.706 | 0.007 | 0.401 | 0.994 |
Child-Pugh classification | 0.546 | 5.189 | 0.240 | 0.023 | 1.727 |
Pre-treatment level of AFP | 0.204 | 0.921 | 0.212 | 0.337 | 1.226 |
Post-treatment level of AFP | -0.931 | 11.238 | 0.278 | 0.001 | 0.394 |
Times of repeated TACE | -0.507 | 20.734 | 0.111 | < 0.001 | 0.602 |
Number of lesions | -0.218 | 0.954 | 0.223 | 0.329 | 0.804 |
Pattern of tumor growth | 0.743 | 16.507 | 0.183 | < 0.001 | 2.102 |
Tumor largest diameter | 0.132 | 31.708 | 0.023 | < 0.001 | 1.141 |
Tumor product of diameters | 0.009 | 30.972 | 0.002 | < 0.001 | 1.009 |
TV | 0.001 | 38.448 | 0.000 | < 0.001 | 1.001 |
TTLVR | 0.662 | 44.113 | 0.100 | < 0.001 | 1.938 |
Portal vein cancerous thrombus | 0.304 | 16.869 | 0.074 | < 0.001 | 1.355 |
Tumor metastasis | 0.287 | 10.160 | 0.090 | 0.001 | 1.333 |
The degree of lipiodol retention | 0.336 | 15.208 | 0.086 | < 0.001 | 1.399 |
TSR | 0.286 | 13.014 | 0.079 | < 0.001 | 1.331 |
PEI | 0.739 | 3.120 | 0.418 | 0.077 | 2.094 |
B: Regression coefficient; AFP: α-fetoprotein; TACE: Transcatheter arterial chemoembolization; TV: Tumor volume; TTLVR: Tumor to liver volume ratio; TSR: Tumor shrinkage ratio; PEI: Percutaneous ethanol injection.